NCT06550765Not yet recruiting
Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors
Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors: A Single-Center, Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 13 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To verify and evaluate the safety and efficacy of biodegradable magnesium metal clips in the surgical margins of radical surgery for bone and soft tissue malignant tumors.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 98 (estimated)
- First submitted
- 21 Jul 2024
- Start date
- 25 Aug 2024
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Guangdong Provincial People's Hospital
- Diseases
- Sarcoma
- NCT number
- NCT06550765
What you commit to
- Study type: Interventional
- Planned participants: 98
- From 25 Aug 2024 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of autoimmune disease, HIV infection, history of immunosuppressive disorder, or currently taking immunosuppressive drugs.
- Participation in any other clinical study currently or within 3 months prior to the screening visit.
Other illness
- Severe dysfunction of the heart, liver, kidney, lung, or brain.
- History of syphilis (Treponema pallidum), active infection with hepatitis B or C, and positive for verified antigens.
Age
- Patients have any other conditions that the researcher deems unsuitable for the study. Age is between 18 to 75 years old.
Other
- Pregnant women or women who are breastfeeding.
Who the study is looking for
- Participants must be of either gender, aged between 18 and 65 years;
- Diagnosis must be confirmed pathologically as osteosarcoma, synovial sarcoma, liposarcoma, or other bone and soft tissue sarcomas;
- Must have undergone standard chemotherapy and require en bloc resection;
- Participants must voluntarily enroll and sign an informed consent form; willing to closely cooperate with the physician to comply with all study requirements, including participation in all follow-up and assessments.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangdong Provincial People's Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.